Global Small Molecule Drugs CDMO Services Market Research Report 2025

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Small Molecule Drugs CDMO Services Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Molecular Drug Intermediates
1.2.3 API
1.2.4 Prepared Products
1.3 Market by Application
1.3.1 Global Small Molecule Drugs CDMO Services Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Clinical
1.3.3 Commercial
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Small Molecule Drugs CDMO Services Market Perspective (2020-2031)
2.2 Global Small Molecule Drugs CDMO Services Growth Trends by Region
2.2.1 Global Small Molecule Drugs CDMO Services Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Small Molecule Drugs CDMO Services Historic Market Size by Region (2020-2025)
2.2.3 Small Molecule Drugs CDMO Services Forecasted Market Size by Region (2026-2031)
2.3 Small Molecule Drugs CDMO Services Market Dynamics
2.3.1 Small Molecule Drugs CDMO Services Industry Trends
2.3.2 Small Molecule Drugs CDMO Services Market Drivers
2.3.3 Small Molecule Drugs CDMO Services Market Challenges
2.3.4 Small Molecule Drugs CDMO Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Small Molecule Drugs CDMO Services Players by Revenue
3.1.1 Global Top Small Molecule Drugs CDMO Services Players by Revenue (2020-2025)
3.1.2 Global Small Molecule Drugs CDMO Services Revenue Market Share by Players (2020-2025)
3.2 Global Top Small Molecule Drugs CDMO Services Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Small Molecule Drugs CDMO Services Revenue
3.4 Global Small Molecule Drugs CDMO Services Market Concentration Ratio
3.4.1 Global Small Molecule Drugs CDMO Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Small Molecule Drugs CDMO Services Revenue in 2024
3.5 Global Key Players of Small Molecule Drugs CDMO Services Head office and Area Served
3.6 Global Key Players of Small Molecule Drugs CDMO Services, Product and Application
3.7 Global Key Players of Small Molecule Drugs CDMO Services, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Small Molecule Drugs CDMO Services Breakdown Data by Type
4.1 Global Small Molecule Drugs CDMO Services Historic Market Size by Type (2020-2025)
4.2 Global Small Molecule Drugs CDMO Services Forecasted Market Size by Type (2026-2031)
5 Small Molecule Drugs CDMO Services Breakdown Data by Application
5.1 Global Small Molecule Drugs CDMO Services Historic Market Size by Application (2020-2025)
5.2 Global Small Molecule Drugs CDMO Services Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Small Molecule Drugs CDMO Services Market Size (2020-2031)
6.2 North America Small Molecule Drugs CDMO Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Small Molecule Drugs CDMO Services Market Size by Country (2020-2025)
6.4 North America Small Molecule Drugs CDMO Services Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Small Molecule Drugs CDMO Services Market Size (2020-2031)
7.2 Europe Small Molecule Drugs CDMO Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Small Molecule Drugs CDMO Services Market Size by Country (2020-2025)
7.4 Europe Small Molecule Drugs CDMO Services Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Small Molecule Drugs CDMO Services Market Size (2020-2031)
8.2 Asia-Pacific Small Molecule Drugs CDMO Services Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Small Molecule Drugs CDMO Services Market Size by Region (2020-2025)
8.4 Asia-Pacific Small Molecule Drugs CDMO Services Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Small Molecule Drugs CDMO Services Market Size (2020-2031)
9.2 Latin America Small Molecule Drugs CDMO Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Small Molecule Drugs CDMO Services Market Size by Country (2020-2025)
9.4 Latin America Small Molecule Drugs CDMO Services Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Small Molecule Drugs CDMO Services Market Size (2020-2031)
10.2 Middle East & Africa Small Molecule Drugs CDMO Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Small Molecule Drugs CDMO Services Market Size by Country (2020-2025)
10.4 Middle East & Africa Small Molecule Drugs CDMO Services Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Catalent
11.1.1 Catalent Company Details
11.1.2 Catalent Business Overview
11.1.3 Catalent Small Molecule Drugs CDMO Services Introduction
11.1.4 Catalent Revenue in Small Molecule Drugs CDMO Services Business (2020-2025)
11.1.5 Catalent Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Small Molecule Drugs CDMO Services Introduction
11.2.4 Thermo Fisher Scientific Revenue in Small Molecule Drugs CDMO Services Business (2020-2025)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Lonza
11.3.1 Lonza Company Details
11.3.2 Lonza Business Overview
11.3.3 Lonza Small Molecule Drugs CDMO Services Introduction
11.3.4 Lonza Revenue in Small Molecule Drugs CDMO Services Business (2020-2025)
11.3.5 Lonza Recent Development
11.4 Siegfried
11.4.1 Siegfried Company Details
11.4.2 Siegfried Business Overview
11.4.3 Siegfried Small Molecule Drugs CDMO Services Introduction
11.4.4 Siegfried Revenue in Small Molecule Drugs CDMO Services Business (2020-2025)
11.4.5 Siegfried Recent Development
11.5 Recipharm
11.5.1 Recipharm Company Details
11.5.2 Recipharm Business Overview
11.5.3 Recipharm Small Molecule Drugs CDMO Services Introduction
11.5.4 Recipharm Revenue in Small Molecule Drugs CDMO Services Business (2020-2025)
11.5.5 Recipharm Recent Development
11.6 Boehringer Ingelheim
11.6.1 Boehringer Ingelheim Company Details
11.6.2 Boehringer Ingelheim Business Overview
11.6.3 Boehringer Ingelheim Small Molecule Drugs CDMO Services Introduction
11.6.4 Boehringer Ingelheim Revenue in Small Molecule Drugs CDMO Services Business (2020-2025)
11.6.5 Boehringer Ingelheim Recent Development
11.7 WuXi AppTech
11.7.1 WuXi AppTech Company Details
11.7.2 WuXi AppTech Business Overview
11.7.3 WuXi AppTech Small Molecule Drugs CDMO Services Introduction
11.7.4 WuXi AppTech Revenue in Small Molecule Drugs CDMO Services Business (2020-2025)
11.7.5 WuXi AppTech Recent Development
11.8 WuXi Biologics
11.8.1 WuXi Biologics Company Details
11.8.2 WuXi Biologics Business Overview
11.8.3 WuXi Biologics Small Molecule Drugs CDMO Services Introduction
11.8.4 WuXi Biologics Revenue in Small Molecule Drugs CDMO Services Business (2020-2025)
11.8.5 WuXi Biologics Recent Development
11.9 Fareva
11.9.1 Fareva Company Details
11.9.2 Fareva Business Overview
11.9.3 Fareva Small Molecule Drugs CDMO Services Introduction
11.9.4 Fareva Revenue in Small Molecule Drugs CDMO Services Business (2020-2025)
11.9.5 Fareva Recent Development
11.10 Samsung Biologics
11.10.1 Samsung Biologics Company Details
11.10.2 Samsung Biologics Business Overview
11.10.3 Samsung Biologics Small Molecule Drugs CDMO Services Introduction
11.10.4 Samsung Biologics Revenue in Small Molecule Drugs CDMO Services Business (2020-2025)
11.10.5 Samsung Biologics Recent Development
11.11 Aenova
11.11.1 Aenova Company Details
11.11.2 Aenova Business Overview
11.11.3 Aenova Small Molecule Drugs CDMO Services Introduction
11.11.4 Aenova Revenue in Small Molecule Drugs CDMO Services Business (2020-2025)
11.11.5 Aenova Recent Development
11.12 Delpharm
11.12.1 Delpharm Company Details
11.12.2 Delpharm Business Overview
11.12.3 Delpharm Small Molecule Drugs CDMO Services Introduction
11.12.4 Delpharm Revenue in Small Molecule Drugs CDMO Services Business (2020-2025)
11.12.5 Delpharm Recent Development
11.13 Strides Pharma
11.13.1 Strides Pharma Company Details
11.13.2 Strides Pharma Business Overview
11.13.3 Strides Pharma Small Molecule Drugs CDMO Services Introduction
11.13.4 Strides Pharma Revenue in Small Molecule Drugs CDMO Services Business (2020-2025)
11.13.5 Strides Pharma Recent Development
11.14 Piramal
11.14.1 Piramal Company Details
11.14.2 Piramal Business Overview
11.14.3 Piramal Small Molecule Drugs CDMO Services Introduction
11.14.4 Piramal Revenue in Small Molecule Drugs CDMO Services Business (2020-2025)
11.14.5 Piramal Recent Development
11.15 Famar
11.15.1 Famar Company Details
11.15.2 Famar Business Overview
11.15.3 Famar Small Molecule Drugs CDMO Services Introduction
11.15.4 Famar Revenue in Small Molecule Drugs CDMO Services Business (2020-2025)
11.15.5 Famar Recent Development
11.16 Curia
11.16.1 Curia Company Details
11.16.2 Curia Business Overview
11.16.3 Curia Small Molecule Drugs CDMO Services Introduction
11.16.4 Curia Revenue in Small Molecule Drugs CDMO Services Business (2020-2025)
11.16.5 Curia Recent Development
11.17 Jubilant
11.17.1 Jubilant Company Details
11.17.2 Jubilant Business Overview
11.17.3 Jubilant Small Molecule Drugs CDMO Services Introduction
11.17.4 Jubilant Revenue in Small Molecule Drugs CDMO Services Business (2020-2025)
11.17.5 Jubilant Recent Development
11.18 Vetter
11.18.1 Vetter Company Details
11.18.2 Vetter Business Overview
11.18.3 Vetter Small Molecule Drugs CDMO Services Introduction
11.18.4 Vetter Revenue in Small Molecule Drugs CDMO Services Business (2020-2025)
11.18.5 Vetter Recent Development
11.19 AGC Pharma Chemicals
11.19.1 AGC Pharma Chemicals Company Details
11.19.2 AGC Pharma Chemicals Business Overview
11.19.3 AGC Pharma Chemicals Small Molecule Drugs CDMO Services Introduction
11.19.4 AGC Pharma Chemicals Revenue in Small Molecule Drugs CDMO Services Business (2020-2025)
11.19.5 AGC Pharma Chemicals Recent Development
11.20 Asymchem
11.20.1 Asymchem Company Details
11.20.2 Asymchem Business Overview
11.20.3 Asymchem Small Molecule Drugs CDMO Services Introduction
11.20.4 Asymchem Revenue in Small Molecule Drugs CDMO Services Business (2020-2025)
11.20.5 Asymchem Recent Development
11.21 Porton
11.21.1 Porton Company Details
11.21.2 Porton Business Overview
11.21.3 Porton Small Molecule Drugs CDMO Services Introduction
11.21.4 Porton Revenue in Small Molecule Drugs CDMO Services Business (2020-2025)
11.21.5 Porton Recent Development
11.22 Eurofins
11.22.1 Eurofins Company Details
11.22.2 Eurofins Business Overview
11.22.3 Eurofins Small Molecule Drugs CDMO Services Introduction
11.22.4 Eurofins Revenue in Small Molecule Drugs CDMO Services Business (2020-2025)
11.22.5 Eurofins Recent Development
11.23 Ascendia Pharmaceuticals
11.23.1 Ascendia Pharmaceuticals Company Details
11.23.2 Ascendia Pharmaceuticals Business Overview
11.23.3 Ascendia Pharmaceuticals Small Molecule Drugs CDMO Services Introduction
11.23.4 Ascendia Pharmaceuticals Revenue in Small Molecule Drugs CDMO Services Business (2020-2025)
11.23.5 Ascendia Pharmaceuticals Recent Development
11.24 Ardena
11.24.1 Ardena Company Details
11.24.2 Ardena Business Overview
11.24.3 Ardena Small Molecule Drugs CDMO Services Introduction
11.24.4 Ardena Revenue in Small Molecule Drugs CDMO Services Business (2020-2025)
11.24.5 Ardena Recent Development
11.25 CPL
11.25.1 CPL Company Details
11.25.2 CPL Business Overview
11.25.3 CPL Small Molecule Drugs CDMO Services Introduction
11.25.4 CPL Revenue in Small Molecule Drugs CDMO Services Business (2020-2025)
11.25.5 CPL Recent Development
11.26 UPM Pharmaceuticals
11.26.1 UPM Pharmaceuticals Company Details
11.26.2 UPM Pharmaceuticals Business Overview
11.26.3 UPM Pharmaceuticals Small Molecule Drugs CDMO Services Introduction
11.26.4 UPM Pharmaceuticals Revenue in Small Molecule Drugs CDMO Services Business (2020-2025)
11.26.5 UPM Pharmaceuticals Recent Development
11.27 FUJIFILM Diosynth Biotechnologies
11.27.1 FUJIFILM Diosynth Biotechnologies Company Details
11.27.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.27.3 FUJIFILM Diosynth Biotechnologies Small Molecule Drugs CDMO Services Introduction
11.27.4 FUJIFILM Diosynth Biotechnologies Revenue in Small Molecule Drugs CDMO Services Business (2020-2025)
11.27.5 FUJIFILM Diosynth Biotechnologies Recent Development
11.28 Groupe Parima
11.28.1 Groupe Parima Company Details
11.28.2 Groupe Parima Business Overview
11.28.3 Groupe Parima Small Molecule Drugs CDMO Services Introduction
11.28.4 Groupe Parima Revenue in Small Molecule Drugs CDMO Services Business (2020-2025)
11.28.5 Groupe Parima Recent Development
11.29 TBD Pharmatech
11.29.1 TBD Pharmatech Company Details
11.29.2 TBD Pharmatech Business Overview
11.29.3 TBD Pharmatech Small Molecule Drugs CDMO Services Introduction
11.29.4 TBD Pharmatech Revenue in Small Molecule Drugs CDMO Services Business (2020-2025)
11.29.5 TBD Pharmatech Recent Development
11.30 Avid Bioservices
11.30.1 Avid Bioservices Company Details
11.30.2 Avid Bioservices Business Overview
11.30.3 Avid Bioservices Small Molecule Drugs CDMO Services Introduction
11.30.4 Avid Bioservices Revenue in Small Molecule Drugs CDMO Services Business (2020-2025)
11.30.5 Avid Bioservices Recent Development
11.31 NextPharma
11.31.1 NextPharma Company Details
11.31.2 NextPharma Business Overview
11.31.3 NextPharma Small Molecule Drugs CDMO Services Introduction
11.31.4 NextPharma Revenue in Small Molecule Drugs CDMO Services Business (2020-2025)
11.31.5 NextPharma Recent Development
11.32 Alcami
11.32.1 Alcami Company Details
11.32.2 Alcami Business Overview
11.32.3 Alcami Small Molecule Drugs CDMO Services Introduction
11.32.4 Alcami Revenue in Small Molecule Drugs CDMO Services Business (2020-2025)
11.32.5 Alcami Recent Development
11.33 Societal CDMO
11.33.1 Societal CDMO Company Details
11.33.2 Societal CDMO Business Overview
11.33.3 Societal CDMO Small Molecule Drugs CDMO Services Introduction
11.33.4 Societal CDMO Revenue in Small Molecule Drugs CDMO Services Business (2020-2025)
11.33.5 Societal CDMO Recent Development
11.34 MedPharm
11.34.1 MedPharm Company Details
11.34.2 MedPharm Business Overview
11.34.3 MedPharm Small Molecule Drugs CDMO Services Introduction
11.34.4 MedPharm Revenue in Small Molecule Drugs CDMO Services Business (2020-2025)
11.34.5 MedPharm Recent Development
11.35 Euroapi
11.35.1 Euroapi Company Details
11.35.2 Euroapi Business Overview
11.35.3 Euroapi Small Molecule Drugs CDMO Services Introduction
11.35.4 Euroapi Revenue in Small Molecule Drugs CDMO Services Business (2020-2025)
11.35.5 Euroapi Recent Development
11.36 BioVectra
11.36.1 BioVectra Company Details
11.36.2 BioVectra Business Overview
11.36.3 BioVectra Small Molecule Drugs CDMO Services Introduction
11.36.4 BioVectra Revenue in Small Molecule Drugs CDMO Services Business (2020-2025)
11.36.5 BioVectra Recent Development
11.37 Pfizer CentreOne
11.37.1 Pfizer CentreOne Company Details
11.37.2 Pfizer CentreOne Business Overview
11.37.3 Pfizer CentreOne Small Molecule Drugs CDMO Services Introduction
11.37.4 Pfizer CentreOne Revenue in Small Molecule Drugs CDMO Services Business (2020-2025)
11.37.5 Pfizer CentreOne Recent Development
11.38 Fermion
11.38.1 Fermion Company Details
11.38.2 Fermion Business Overview
11.38.3 Fermion Small Molecule Drugs CDMO Services Introduction
11.38.4 Fermion Revenue in Small Molecule Drugs CDMO Services Business (2020-2025)
11.38.5 Fermion Recent Development
11.39 Lundbeck
11.39.1 Lundbeck Company Details
11.39.2 Lundbeck Business Overview
11.39.3 Lundbeck Small Molecule Drugs CDMO Services Introduction
11.39.4 Lundbeck Revenue in Small Molecule Drugs CDMO Services Business (2020-2025)
11.39.5 Lundbeck Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Small Molecule Drugs CDMO Services Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Molecular Drug Intermediates
Table 3. Key Players of API
Table 4. Key Players of Prepared Products
Table 5. Global Small Molecule Drugs CDMO Services Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Small Molecule Drugs CDMO Services Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Small Molecule Drugs CDMO Services Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Small Molecule Drugs CDMO Services Market Share by Region (2020-2025)
Table 9. Global Small Molecule Drugs CDMO Services Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Small Molecule Drugs CDMO Services Market Share by Region (2026-2031)
Table 11. Small Molecule Drugs CDMO Services Market Trends
Table 12. Small Molecule Drugs CDMO Services Market Drivers
Table 13. Small Molecule Drugs CDMO Services Market Challenges
Table 14. Small Molecule Drugs CDMO Services Market Restraints
Table 15. Global Small Molecule Drugs CDMO Services Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Small Molecule Drugs CDMO Services Market Share by Players (2020-2025)
Table 17. Global Top Small Molecule Drugs CDMO Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule Drugs CDMO Services as of 2024)
Table 18. Ranking of Global Top Small Molecule Drugs CDMO Services Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Small Molecule Drugs CDMO Services Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Small Molecule Drugs CDMO Services, Headquarters and Area Served
Table 21. Global Key Players of Small Molecule Drugs CDMO Services, Product and Application
Table 22. Global Key Players of Small Molecule Drugs CDMO Services, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Small Molecule Drugs CDMO Services Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Small Molecule Drugs CDMO Services Revenue Market Share by Type (2020-2025)
Table 26. Global Small Molecule Drugs CDMO Services Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Small Molecule Drugs CDMO Services Revenue Market Share by Type (2026-2031)
Table 28. Global Small Molecule Drugs CDMO Services Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Small Molecule Drugs CDMO Services Revenue Market Share by Application (2020-2025)
Table 30. Global Small Molecule Drugs CDMO Services Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Small Molecule Drugs CDMO Services Revenue Market Share by Application (2026-2031)
Table 32. North America Small Molecule Drugs CDMO Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Small Molecule Drugs CDMO Services Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Small Molecule Drugs CDMO Services Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Small Molecule Drugs CDMO Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Small Molecule Drugs CDMO Services Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Small Molecule Drugs CDMO Services Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Small Molecule Drugs CDMO Services Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Small Molecule Drugs CDMO Services Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Small Molecule Drugs CDMO Services Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Small Molecule Drugs CDMO Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Small Molecule Drugs CDMO Services Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Small Molecule Drugs CDMO Services Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Small Molecule Drugs CDMO Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Small Molecule Drugs CDMO Services Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Small Molecule Drugs CDMO Services Market Size by Country (2026-2031) & (US$ Million)
Table 47. Catalent Company Details
Table 48. Catalent Business Overview
Table 49. Catalent Small Molecule Drugs CDMO Services Product
Table 50. Catalent Revenue in Small Molecule Drugs CDMO Services Business (2020-2025) & (US$ Million)
Table 51. Catalent Recent Development
Table 52. Thermo Fisher Scientific Company Details
Table 53. Thermo Fisher Scientific Business Overview
Table 54. Thermo Fisher Scientific Small Molecule Drugs CDMO Services Product
Table 55. Thermo Fisher Scientific Revenue in Small Molecule Drugs CDMO Services Business (2020-2025) & (US$ Million)
Table 56. Thermo Fisher Scientific Recent Development
Table 57. Lonza Company Details
Table 58. Lonza Business Overview
Table 59. Lonza Small Molecule Drugs CDMO Services Product
Table 60. Lonza Revenue in Small Molecule Drugs CDMO Services Business (2020-2025) & (US$ Million)
Table 61. Lonza Recent Development
Table 62. Siegfried Company Details
Table 63. Siegfried Business Overview
Table 64. Siegfried Small Molecule Drugs CDMO Services Product
Table 65. Siegfried Revenue in Small Molecule Drugs CDMO Services Business (2020-2025) & (US$ Million)
Table 66. Siegfried Recent Development
Table 67. Recipharm Company Details
Table 68. Recipharm Business Overview
Table 69. Recipharm Small Molecule Drugs CDMO Services Product
Table 70. Recipharm Revenue in Small Molecule Drugs CDMO Services Business (2020-2025) & (US$ Million)
Table 71. Recipharm Recent Development
Table 72. Boehringer Ingelheim Company Details
Table 73. Boehringer Ingelheim Business Overview
Table 74. Boehringer Ingelheim Small Molecule Drugs CDMO Services Product
Table 75. Boehringer Ingelheim Revenue in Small Molecule Drugs CDMO Services Business (2020-2025) & (US$ Million)
Table 76. Boehringer Ingelheim Recent Development
Table 77. WuXi AppTech Company Details
Table 78. WuXi AppTech Business Overview
Table 79. WuXi AppTech Small Molecule Drugs CDMO Services Product
Table 80. WuXi AppTech Revenue in Small Molecule Drugs CDMO Services Business (2020-2025) & (US$ Million)
Table 81. WuXi AppTech Recent Development
Table 82. WuXi Biologics Company Details
Table 83. WuXi Biologics Business Overview
Table 84. WuXi Biologics Small Molecule Drugs CDMO Services Product
Table 85. WuXi Biologics Revenue in Small Molecule Drugs CDMO Services Business (2020-2025) & (US$ Million)
Table 86. WuXi Biologics Recent Development
Table 87. Fareva Company Details
Table 88. Fareva Business Overview
Table 89. Fareva Small Molecule Drugs CDMO Services Product
Table 90. Fareva Revenue in Small Molecule Drugs CDMO Services Business (2020-2025) & (US$ Million)
Table 91. Fareva Recent Development
Table 92. Samsung Biologics Company Details
Table 93. Samsung Biologics Business Overview
Table 94. Samsung Biologics Small Molecule Drugs CDMO Services Product
Table 95. Samsung Biologics Revenue in Small Molecule Drugs CDMO Services Business (2020-2025) & (US$ Million)
Table 96. Samsung Biologics Recent Development
Table 97. Aenova Company Details
Table 98. Aenova Business Overview
Table 99. Aenova Small Molecule Drugs CDMO Services Product
Table 100. Aenova Revenue in Small Molecule Drugs CDMO Services Business (2020-2025) & (US$ Million)
Table 101. Aenova Recent Development
Table 102. Delpharm Company Details
Table 103. Delpharm Business Overview
Table 104. Delpharm Small Molecule Drugs CDMO Services Product
Table 105. Delpharm Revenue in Small Molecule Drugs CDMO Services Business (2020-2025) & (US$ Million)
Table 106. Delpharm Recent Development
Table 107. Strides Pharma Company Details
Table 108. Strides Pharma Business Overview
Table 109. Strides Pharma Small Molecule Drugs CDMO Services Product
Table 110. Strides Pharma Revenue in Small Molecule Drugs CDMO Services Business (2020-2025) & (US$ Million)
Table 111. Strides Pharma Recent Development
Table 112. Piramal Company Details
Table 113. Piramal Business Overview
Table 114. Piramal Small Molecule Drugs CDMO Services Product
Table 115. Piramal Revenue in Small Molecule Drugs CDMO Services Business (2020-2025) & (US$ Million)
Table 116. Piramal Recent Development
Table 117. Famar Company Details
Table 118. Famar Business Overview
Table 119. Famar Small Molecule Drugs CDMO Services Product
Table 120. Famar Revenue in Small Molecule Drugs CDMO Services Business (2020-2025) & (US$ Million)
Table 121. Famar Recent Development
Table 122. Curia Company Details
Table 123. Curia Business Overview
Table 124. Curia Small Molecule Drugs CDMO Services Product
Table 125. Curia Revenue in Small Molecule Drugs CDMO Services Business (2020-2025) & (US$ Million)
Table 126. Curia Recent Development
Table 127. Jubilant Company Details
Table 128. Jubilant Business Overview
Table 129. Jubilant Small Molecule Drugs CDMO Services Product
Table 130. Jubilant Revenue in Small Molecule Drugs CDMO Services Business (2020-2025) & (US$ Million)
Table 131. Jubilant Recent Development
Table 132. Vetter Company Details
Table 133. Vetter Business Overview
Table 134. Vetter Small Molecule Drugs CDMO Services Product
Table 135. Vetter Revenue in Small Molecule Drugs CDMO Services Business (2020-2025) & (US$ Million)
Table 136. Vetter Recent Development
Table 137. AGC Pharma Chemicals Company Details
Table 138. AGC Pharma Chemicals Business Overview
Table 139. AGC Pharma Chemicals Small Molecule Drugs CDMO Services Product
Table 140. AGC Pharma Chemicals Revenue in Small Molecule Drugs CDMO Services Business (2020-2025) & (US$ Million)
Table 141. AGC Pharma Chemicals Recent Development
Table 142. Asymchem Company Details
Table 143. Asymchem Business Overview
Table 144. Asymchem Small Molecule Drugs CDMO Services Product
Table 145. Asymchem Revenue in Small Molecule Drugs CDMO Services Business (2020-2025) & (US$ Million)
Table 146. Asymchem Recent Development
Table 147. Porton Company Details
Table 148. Porton Business Overview
Table 149. Porton Small Molecule Drugs CDMO Services Product
Table 150. Porton Revenue in Small Molecule Drugs CDMO Services Business (2020-2025) & (US$ Million)
Table 151. Porton Recent Development
Table 152. Eurofins Company Details
Table 153. Eurofins Business Overview
Table 154. Eurofins Small Molecule Drugs CDMO Services Product
Table 155. Eurofins Revenue in Small Molecule Drugs CDMO Services Business (2020-2025) & (US$ Million)
Table 156. Eurofins Recent Development
Table 157. Ascendia Pharmaceuticals Company Details
Table 158. Ascendia Pharmaceuticals Business Overview
Table 159. Ascendia Pharmaceuticals Small Molecule Drugs CDMO Services Product
Table 160. Ascendia Pharmaceuticals Revenue in Small Molecule Drugs CDMO Services Business (2020-2025) & (US$ Million)
Table 161. Ascendia Pharmaceuticals Recent Development
Table 162. Ardena Company Details
Table 163. Ardena Business Overview
Table 164. Ardena Small Molecule Drugs CDMO Services Product
Table 165. Ardena Revenue in Small Molecule Drugs CDMO Services Business (2020-2025) & (US$ Million)
Table 166. Ardena Recent Development
Table 167. CPL Company Details
Table 168. CPL Business Overview
Table 169. CPL Small Molecule Drugs CDMO Services Product
Table 170. CPL Revenue in Small Molecule Drugs CDMO Services Business (2020-2025) & (US$ Million)
Table 171. CPL Recent Development
Table 172. UPM Pharmaceuticals Company Details
Table 173. UPM Pharmaceuticals Business Overview
Table 174. UPM Pharmaceuticals Small Molecule Drugs CDMO Services Product
Table 175. UPM Pharmaceuticals Revenue in Small Molecule Drugs CDMO Services Business (2020-2025) & (US$ Million)
Table 176. UPM Pharmaceuticals Recent Development
Table 177. FUJIFILM Diosynth Biotechnologies Company Details
Table 178. FUJIFILM Diosynth Biotechnologies Business Overview
Table 179. FUJIFILM Diosynth Biotechnologies Small Molecule Drugs CDMO Services Product
Table 180. FUJIFILM Diosynth Biotechnologies Revenue in Small Molecule Drugs CDMO Services Business (2020-2025) & (US$ Million)
Table 181. FUJIFILM Diosynth Biotechnologies Recent Development
Table 182. Groupe Parima Company Details
Table 183. Groupe Parima Business Overview
Table 184. Groupe Parima Small Molecule Drugs CDMO Services Product
Table 185. Groupe Parima Revenue in Small Molecule Drugs CDMO Services Business (2020-2025) & (US$ Million)
Table 186. Groupe Parima Recent Development
Table 187. TBD Pharmatech Company Details
Table 188. TBD Pharmatech Business Overview
Table 189. TBD Pharmatech Small Molecule Drugs CDMO Services Product
Table 190. TBD Pharmatech Revenue in Small Molecule Drugs CDMO Services Business (2020-2025) & (US$ Million)
Table 191. TBD Pharmatech Recent Development
Table 192. Avid Bioservices Company Details
Table 193. Avid Bioservices Business Overview
Table 194. Avid Bioservices Small Molecule Drugs CDMO Services Product
Table 195. Avid Bioservices Revenue in Small Molecule Drugs CDMO Services Business (2020-2025) & (US$ Million)
Table 196. Avid Bioservices Recent Development
Table 197. NextPharma Company Details
Table 198. NextPharma Business Overview
Table 199. NextPharma Small Molecule Drugs CDMO Services Product
Table 200. NextPharma Revenue in Small Molecule Drugs CDMO Services Business (2020-2025) & (US$ Million)
Table 201. NextPharma Recent Development
Table 202. Alcami Company Details
Table 203. Alcami Business Overview
Table 204. Alcami Small Molecule Drugs CDMO Services Product
Table 205. Alcami Revenue in Small Molecule Drugs CDMO Services Business (2020-2025) & (US$ Million)
Table 206. Alcami Recent Development
Table 207. Societal CDMO Company Details
Table 208. Societal CDMO Business Overview
Table 209. Societal CDMO Small Molecule Drugs CDMO Services Product
Table 210. Societal CDMO Revenue in Small Molecule Drugs CDMO Services Business (2020-2025) & (US$ Million)
Table 211. Societal CDMO Recent Development
Table 212. MedPharm Company Details
Table 213. MedPharm Business Overview
Table 214. MedPharm Small Molecule Drugs CDMO Services Product
Table 215. MedPharm Revenue in Small Molecule Drugs CDMO Services Business (2020-2025) & (US$ Million)
Table 216. MedPharm Recent Development
Table 217. Euroapi Company Details
Table 218. Euroapi Business Overview
Table 219. Euroapi Small Molecule Drugs CDMO Services Product
Table 220. Euroapi Revenue in Small Molecule Drugs CDMO Services Business (2020-2025) & (US$ Million)
Table 221. Euroapi Recent Development
Table 222. BioVectra Company Details
Table 223. BioVectra Business Overview
Table 224. BioVectra Small Molecule Drugs CDMO Services Product
Table 225. BioVectra Revenue in Small Molecule Drugs CDMO Services Business (2020-2025) & (US$ Million)
Table 226. BioVectra Recent Development
Table 227. Pfizer CentreOne Company Details
Table 228. Pfizer CentreOne Business Overview
Table 229. Pfizer CentreOne Small Molecule Drugs CDMO Services Product
Table 230. Pfizer CentreOne Revenue in Small Molecule Drugs CDMO Services Business (2020-2025) & (US$ Million)
Table 231. Pfizer CentreOne Recent Development
Table 232. Fermion Company Details
Table 233. Fermion Business Overview
Table 234. Fermion Small Molecule Drugs CDMO Services Product
Table 235. Fermion Revenue in Small Molecule Drugs CDMO Services Business (2020-2025) & (US$ Million)
Table 236. Fermion Recent Development
Table 237. Lundbeck Company Details
Table 238. Lundbeck Business Overview
Table 239. Lundbeck Small Molecule Drugs CDMO Services Product
Table 240. Lundbeck Revenue in Small Molecule Drugs CDMO Services Business (2020-2025) & (US$ Million)
Table 241. Lundbeck Recent Development
Table 242. Research Programs/Design for This Report
Table 243. Key Data Information from Secondary Sources
Table 244. Key Data Information from Primary Sources
Table 245. Authors List of This Report


List of Figures
Figure 1. Small Molecule Drugs CDMO Services Picture
Figure 2. Global Small Molecule Drugs CDMO Services Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Small Molecule Drugs CDMO Services Market Share by Type: 2024 VS 2031
Figure 4. Molecular Drug Intermediates Features
Figure 5. API Features
Figure 6. Prepared Products Features
Figure 7. Global Small Molecule Drugs CDMO Services Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Small Molecule Drugs CDMO Services Market Share by Application: 2024 VS 2031
Figure 9. Clinical Case Studies
Figure 10. Commercial Case Studies
Figure 11. Small Molecule Drugs CDMO Services Report Years Considered
Figure 12. Global Small Molecule Drugs CDMO Services Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Small Molecule Drugs CDMO Services Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Small Molecule Drugs CDMO Services Market Share by Region: 2024 VS 2031
Figure 15. Global Small Molecule Drugs CDMO Services Market Share by Players in 2024
Figure 16. Global Small Molecule Drugs CDMO Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 17. The Top 10 and 5 Players Market Share by Small Molecule Drugs CDMO Services Revenue in 2024
Figure 18. North America Small Molecule Drugs CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Small Molecule Drugs CDMO Services Market Share by Country (2020-2031)
Figure 20. United States Small Molecule Drugs CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Small Molecule Drugs CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Small Molecule Drugs CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Small Molecule Drugs CDMO Services Market Share by Country (2020-2031)
Figure 24. Germany Small Molecule Drugs CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Small Molecule Drugs CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Small Molecule Drugs CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Small Molecule Drugs CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Small Molecule Drugs CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Ireland Small Molecule Drugs CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Small Molecule Drugs CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Small Molecule Drugs CDMO Services Market Share by Region (2020-2031)
Figure 32. China Small Molecule Drugs CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Small Molecule Drugs CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Small Molecule Drugs CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Small Molecule Drugs CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Small Molecule Drugs CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia & New Zealand Small Molecule Drugs CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Small Molecule Drugs CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Small Molecule Drugs CDMO Services Market Share by Country (2020-2031)
Figure 40. Mexico Small Molecule Drugs CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Small Molecule Drugs CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Small Molecule Drugs CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Small Molecule Drugs CDMO Services Market Share by Country (2020-2031)
Figure 44. Israel Small Molecule Drugs CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Small Molecule Drugs CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Small Molecule Drugs CDMO Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Catalent Revenue Growth Rate in Small Molecule Drugs CDMO Services Business (2020-2025)
Figure 48. Thermo Fisher Scientific Revenue Growth Rate in Small Molecule Drugs CDMO Services Business (2020-2025)
Figure 49. Lonza Revenue Growth Rate in Small Molecule Drugs CDMO Services Business (2020-2025)
Figure 50. Siegfried Revenue Growth Rate in Small Molecule Drugs CDMO Services Business (2020-2025)
Figure 51. Recipharm Revenue Growth Rate in Small Molecule Drugs CDMO Services Business (2020-2025)
Figure 52. Boehringer Ingelheim Revenue Growth Rate in Small Molecule Drugs CDMO Services Business (2020-2025)
Figure 53. WuXi AppTech Revenue Growth Rate in Small Molecule Drugs CDMO Services Business (2020-2025)
Figure 54. WuXi Biologics Revenue Growth Rate in Small Molecule Drugs CDMO Services Business (2020-2025)
Figure 55. Fareva Revenue Growth Rate in Small Molecule Drugs CDMO Services Business (2020-2025)
Figure 56. Samsung Biologics Revenue Growth Rate in Small Molecule Drugs CDMO Services Business (2020-2025)
Figure 57. Aenova Revenue Growth Rate in Small Molecule Drugs CDMO Services Business (2020-2025)
Figure 58. Delpharm Revenue Growth Rate in Small Molecule Drugs CDMO Services Business (2020-2025)
Figure 59. Strides Pharma Revenue Growth Rate in Small Molecule Drugs CDMO Services Business (2020-2025)
Figure 60. Piramal Revenue Growth Rate in Small Molecule Drugs CDMO Services Business (2020-2025)
Figure 61. Famar Revenue Growth Rate in Small Molecule Drugs CDMO Services Business (2020-2025)
Figure 62. Curia Revenue Growth Rate in Small Molecule Drugs CDMO Services Business (2020-2025)
Figure 63. Jubilant Revenue Growth Rate in Small Molecule Drugs CDMO Services Business (2020-2025)
Figure 64. Vetter Revenue Growth Rate in Small Molecule Drugs CDMO Services Business (2020-2025)
Figure 65. AGC Pharma Chemicals Revenue Growth Rate in Small Molecule Drugs CDMO Services Business (2020-2025)
Figure 66. Asymchem Revenue Growth Rate in Small Molecule Drugs CDMO Services Business (2020-2025)
Figure 67. Porton Revenue Growth Rate in Small Molecule Drugs CDMO Services Business (2020-2025)
Figure 68. Eurofins Revenue Growth Rate in Small Molecule Drugs CDMO Services Business (2020-2025)
Figure 69. Ascendia Pharmaceuticals Revenue Growth Rate in Small Molecule Drugs CDMO Services Business (2020-2025)
Figure 70. Ardena Revenue Growth Rate in Small Molecule Drugs CDMO Services Business (2020-2025)
Figure 71. CPL Revenue Growth Rate in Small Molecule Drugs CDMO Services Business (2020-2025)
Figure 72. UPM Pharmaceuticals Revenue Growth Rate in Small Molecule Drugs CDMO Services Business (2020-2025)
Figure 73. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Small Molecule Drugs CDMO Services Business (2020-2025)
Figure 74. Groupe Parima Revenue Growth Rate in Small Molecule Drugs CDMO Services Business (2020-2025)
Figure 75. TBD Pharmatech Revenue Growth Rate in Small Molecule Drugs CDMO Services Business (2020-2025)
Figure 76. Avid Bioservices Revenue Growth Rate in Small Molecule Drugs CDMO Services Business (2020-2025)
Figure 77. NextPharma Revenue Growth Rate in Small Molecule Drugs CDMO Services Business (2020-2025)
Figure 78. Alcami Revenue Growth Rate in Small Molecule Drugs CDMO Services Business (2020-2025)
Figure 79. Societal CDMO Revenue Growth Rate in Small Molecule Drugs CDMO Services Business (2020-2025)
Figure 80. MedPharm Revenue Growth Rate in Small Molecule Drugs CDMO Services Business (2020-2025)
Figure 81. Euroapi Revenue Growth Rate in Small Molecule Drugs CDMO Services Business (2020-2025)
Figure 82. BioVectra Revenue Growth Rate in Small Molecule Drugs CDMO Services Business (2020-2025)
Figure 83. Pfizer CentreOne Revenue Growth Rate in Small Molecule Drugs CDMO Services Business (2020-2025)
Figure 84. Fermion Revenue Growth Rate in Small Molecule Drugs CDMO Services Business (2020-2025)
Figure 85. Lundbeck Revenue Growth Rate in Small Molecule Drugs CDMO Services Business (2020-2025)
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed

Your Name

Your E-mail

Your message

Submit